Yano, Shiza Doaa .
HRN: 23-65-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2023
MUPIROCIN 2%, 15G (TUBE)
09/09/2023
09/13/2023
TOPICAL
Apply Thinly
BID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes